Literature DB >> 29194759

Association between urine retinol-binding protein levels and nonalcoholic fatty liver disease: A cross-sectional study in Chinese population.

Juanwen Zhang1, Zeyu Liu2, Xuyao Zhang3, Li Zhang4, Xi Jin5.   

Abstract

OBJECTIVE: The prevalence of nonalcoholic fatty liver disease (NAFLD) has been rapidly increased, becoming a public health problem worldwide. Our objective was to investigate the association between urine retinol-binding protein (RBP) and NAFLD in a Chinese population and develop a multivariate logistic regression model for NAFLD prediction.
METHODS: A total of 317 NAFLD patients and 391 healthy controls were enrolled in this cross-sectional study based on inclusion and exclusion criteria, from whom fasting urine and blood were collected for further study. Urine RBP level and other parameters were measured and compared between NAFLD subjects and controls.
RESULTS: Urine RBP levels (expressed by RBP/creatinine ratio) in NAFLD patients were significantly higher than controls (median 133.1 mg/g vs 110.7 mg/g; P < .001). Urine RBP/creatinine ratio was verified as an independent factor for NAFLD prediction after adjustment in multivariate logistic regression. The area under curve (AUC) of receiver operating characteristic (ROC) was 0.889 with the 95% confidence interval from 0.867 to 0.912.With a cutoff point of 0.215, the sensitivity and specificity of urine RBP/creatinine ratio in NAFLD prediction were 81.1% and 84.5%, respectively.
CONCLUSION: Our results demonstrated that urine RBP/creatinine ratio was an independent risk factor for NAFLD while the predictive model for NAFLD diagnosis is noninvasive with high sensitivity and specificity.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  nonalcoholic fatty liver disease; retinol-binding protein

Mesh:

Substances:

Year:  2017        PMID: 29194759      PMCID: PMC6817258          DOI: 10.1002/jcla.22359

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  36 in total

Review 1.  Nonalcoholic fatty liver disease.

Authors:  Paul Angulo
Journal:  N Engl J Med       Date:  2002-04-18       Impact factor: 91.245

2.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

Authors:  Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke
Journal:  Lancet       Date:  2007-10-20       Impact factor: 79.321

3.  Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases.

Authors:  Min De Zeng; Jian Gao Fan; Lun Gen Lu; You Ming Li; Cheng Wei Chen; Bing Yuan Wang; Yi Min Mao
Journal:  J Dig Dis       Date:  2008-05       Impact factor: 2.325

4.  Steatohepatitis: a tale of two "hits"?

Authors:  C P Day; O F James
Journal:  Gastroenterology       Date:  1998-04       Impact factor: 22.682

5.  The retinol-binding protein receptor STRA6 regulates diurnal insulin responses.

Authors:  Christy M Gliniak; J Mark Brown; Noa Noy
Journal:  J Biol Chem       Date:  2017-07-21       Impact factor: 5.157

Review 6.  Emerging Liver-Kidney Interactions in Nonalcoholic Fatty Liver Disease.

Authors:  Giovanni Musso; Maurizio Cassader; Solomon Cohney; Silvia Pinach; Francesca Saba; Roberto Gambino
Journal:  Trends Mol Med       Date:  2015-10       Impact factor: 11.951

7.  Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women.

Authors:  Sachin S Kunde; Audrey J Lazenby; Ronald H Clements; Gary A Abrams
Journal:  Hepatology       Date:  2005-09       Impact factor: 17.425

8.  Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease.

Authors:  Kerry-Lee Milner; David van der Poorten; Aimin Xu; Elisabetta Bugianesi; James G Kench; Karen S L Lam; Donald J Chisholm; Jacob George
Journal:  Hepatology       Date:  2009-06       Impact factor: 17.425

9.  Retinol binding protein-4 circulating levels were higher in nonalcoholic fatty liver disease vs. histologically normal liver from morbidly obese women.

Authors:  Ximena Terra; Teresa Auguet; Montserrat Broch; Fàtima Sabench; Mercè Hernández; Rosa M Pastor; Isabel M Quesada; Anna Luna; Carmen Aguilar; Daniel del Castillo; Cristóbal Richart
Journal:  Obesity (Silver Spring)       Date:  2013-01       Impact factor: 5.002

10.  HDMCP uncouples yeast mitochondrial respiration and alleviates steatosis in L02 and hepG2 cells by decreasing ATP and H2O2 levels: a novel mechanism for NAFLD.

Authors:  Xi Jin; Yi-da Yang; Kun Chen; Zhi-yuan Lv; Lin Zheng; Ya-ping Liu; Shao-hua Chen; Chao-hui Yu; Xue-yuan Jiang; Cheng-yu Zhang; You-ming Li
Journal:  J Hepatol       Date:  2009-01-03       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.